Recon: FDA approves Abbott’s TriClip heart valve repair device; Teva, Viatris revive patent challenge against J&J schizophrenia drug
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States